Wikidata

(Q61956801)

English

A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma

clinical trial

In more languages

Statements

title
A Phase 1b Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ-26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Subjects With Relapsed Multiple Myeloma (English)
0 references
country
France
0 references
start time
September 2011
0 references
end time
November 2013
0 references
number of participants
18
0 references
minimum age
18 year
0 references
maximum age
99 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61956801&oldid=2149093253"